Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | EGFR | P00533 | 2/20 | 0.51 |
| ▸ | GALR2 | O43603 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | SYK | P43405 | 1/20 | 0.51 |
| ▸ | VCP | P55072 | 1/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | KRAS | P01116 | 2/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14125352 | 0.84 | CXCL12 (0.62) | MAPTHTTALDH1A1AKR1C3POLB | |
| SCHEMBL14125351 | 0.84 | CXCL12 (0.62) | MAPTHTTALDH1A1AKR1C3POLB | |
| SCHEMBL2951324 | 0.83 | MEN1 (0.62) | MAPTGAAHTTEGFRALDH1A1 | |
| SCHEMBL2523113 | 0.83 | MEN1 (0.62) | MAPTGAAHTTEGFRALDH1A1 | |
| SCHEMBL2951322 | 0.83 | MEN1 (0.62) | MAPTGAAHTTEGFRALDH1A1 | |
| SCHEMBL28461838 | 0.82 | AKR1C3 (0.75) | AKR1C3PTGS2 | |
| SCHEMBL28899315 | 0.82 | AKR1C3 (0.75) | AKR1C3PTGS2 | |
| SCHEMBL25278547 | 0.80 | KRAS (0.74) | KRASCXCL12 | |
| SCHEMBL25198097 | 0.80 | KRAS (0.74) | KRASCXCL12 | |
| SCHEMBL4254966 | 0.79 | PTGS2 (0.76) | MAPTGAAHTTLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1039 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624376-B2 | Mutants of a filamentous fungal cell having increased productivity in the production of a polypeptide | NOVOZYMES A/S (DK) | 2026-05-12 | — | — | US | disclosed |
| EP-3894551-B1 | POLYPEPTIDES HAVING XYLANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES AS (DK) | 2026-04-22 | — | — | EP | disclosed |
| US-12600996-B2 | Carbohydrate binding module variants and hybrid polypeptides comprising same | NOVOZYMES A/S (DK) | 2026-04-14 | — | — | US | disclosed |
| US-20250270531-A1 | GH61 VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES A/S (DK) | 2025-08-28 | — | — | US | disclosed |
| US-12385027-B2 | Polypeptides having xylanase activity and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2025-08-12 | — | — | US | disclosed |
| US-12331332-B2 | GH61 variants and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2025-06-17 | — | — | US | disclosed |
| US-20250122545-A1 | COMPOSITIONS FOR SACCHARIFICATION OF CELLULOSIC MATERIAL | NOVOZYMES, INC. (US) | 2025-04-17 | — | — | US | disclosed |
| US-20250092434-A1 | CELLULOLYTIC ENZYME COMPOSITIONS AND USES THEREOF | NOVOZYMES, INC. (US) | 2025-03-20 | — | — | US | disclosed |
| US-12234493-B2 | Compositions for saccharification of cellulosic material | NOVOZYMES, INC. (US) | 2025-02-25 | — | — | US | disclosed |
| US-12195776-B2 | Cellulolytic enzyme compositions and uses thereof | NOVOZYMES, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| WO-2009127729-A1 | POLYPEPTIDES HAVING FERULIC ACID ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES A/S (DK) | 2009-10-22 | — | — | WO | disclosed |
| US-20090162913-A1 | FERULATE ESTERASE PRODUCING STRAINS FOR THE ENHANCEMENT OF BIOGAS PRODUCTION | PIONEER HI-BRED INTERNATIONAL, INC. | 2009-06-25 | — | — | US | disclosed |
| WO-2009076122-A1 | POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES A/S (DK) | 2009-06-18 | — | — | WO | disclosed |
| US-20090151026-A1 | Polypeptides having feruloyl esterase activity and polynucleotides encoding same | NOVOZYMES A/S (DK) | 2009-06-11 | — | — | US | disclosed |
| WO-2009065934-A1 | POLYPEPTIDES HAVING FERULIC ACID ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES A/S (DK) | 2009-05-28 | — | — | WO | disclosed |
| US-20090010903-A1 | using ferulate esterase producing bacterial strains or functional mutants thereof as a silage inoculant for improving fiber digestibility; treating pre-ensiled plant material to enhance the digestibility of the resulting silage | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2009-01-08 | — | — | US | disclosed |
| US-20090011085-A1 | using ferulate esterase producing bacterial strains or functional mutants thereof as a silage inoculant for improving fiber digestibility; treating pre-ensiled plant material to enhance the digestibility of the resulting silage | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2009-01-08 | — | — | US | disclosed |
| EP-1784085-A1 | FERULATE ESTERASE PRODUCING STRAINS AND METHODS OF USING SAME | Pioneer-Hi-Bred International, Inc. (US) | 2007-05-16 | — | — | EP | disclosed |
| WO-2006026763-A1 | FERULATE ESTERASE PRODUCING STRAINS AND METHODS OF USING SAME | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2006-03-09 | — | — | WO | disclosed |
| US-20060046292-A1 | using ferulate esterase producing bacterial strains or functional mutants thereof as a silage inoculant for improving fiber digestibility; treating pre-ensiled plant material to enhance the digestibility of the resulting silage | PIONEER HI-BRED INTERNATIONAL, INC. | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600996-B2 | Carbohydrate binding module variants and hybrid polypeptides comprising same | QPCTL, DNTT, RNGTT | MAPT 1179/4885GAA 2748/4885HTT 1686/4885 |
| US-12624376-B2 | Mutants of a filamentous fungal cell having increased productivity in the production of a polypeptide | CDC42, RAC1, RAC2 | MAPT 3944/4885GAA 4313/4885HTT 4411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.